LARIMAR THERAPEUTICS INC. - COMMON STOCK
2,2400
08-мая-25 16:45:00
15 мин. задержка
Акции
+0,0700
+3,23%
Сегодняшний диапазон
2,0500 - 2,3300
ISIN
N/A
Источник
NASDAQ
- Котировки
- Графики
Новости
- Статистика
-
Larimar Therapeutics Reports First Quarter 2025 Financial Results
30 апр 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
24 мар 2025 07:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the Leerink Partners Global Healthcare Conference
03 мар 2025 16:05:00 Источник Nasdaq GlobeNewswire
-
23 янв 2025 16:05:00 Источник Nasdaq GlobeNewswire
-
16 дек 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
18 ноя 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Third Quarter 2024 Operating and Financial Results
30 окт 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
19 сен 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics to Participate in Upcoming Investor Conferences
27 авг 2024 08:00:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports Second Quarter 2024 Operating and Financial Results
07 авг 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
30 май 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
20 май 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
09 май 2024 07:00:00 Источник Nasdaq GlobeNewswire
-
14 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
11 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics to Present at the Leerink Partners Global Biopharma Conference
06 мар 2024 16:05:00 Источник Nasdaq GlobeNewswire
-
16 фев 2024 16:20:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Pricing of Underwritten Public Offering of Common Stock
14 фев 2024 06:15:00 Источник Nasdaq GlobeNewswire
-
Larimar Therapeutics Announces Proposed Underwritten Public Offering
13 фев 2024 16:18:34 Источник Nasdaq GlobeNewswire
-
12 фев 2024 07:00:00 Источник Nasdaq GlobeNewswire
- <<
- <
- 1
- >